Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-675250
Filing Date
2016-08-08
Accepted
2016-08-08 16:49:54
Documents
43
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d223169d10q.htm 10-Q 429526
2 EX-31.1 d223169dex311.htm EX-31.1 9000
3 EX-31.2 d223169dex312.htm EX-31.2 9308
4 EX-32.1 d223169dex321.htm EX-32.1 5180
  Complete submission text file 0001193125-16-675250.txt   2466062

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20160630.xml EX-101.INS 433039
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20160630.xsd EX-101.SCH 27912
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20160630_cal.xml EX-101.CAL 22984
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20160630_def.xml EX-101.DEF 199558
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20160630_lab.xml EX-101.LAB 182544
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20160630_pre.xml EX-101.PRE 210464
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 161814816
SIC: 2834 Pharmaceutical Preparations